Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Net Cash Flow (2016 - 2026)

Biomerica's Net Cash Flow history spans 17 years, with the latest figure at -$1.2 million for Q1 2026.

  • Quarterly results put Net Cash Flow at -$1.2 million for Q1 2026, down 273.07% from a year ago — trailing twelve months through Feb 2026 was -$1.7 million (up 31.96% YoY), and the annual figure for FY2025 was -$1.8 million, up 68.2%.
  • Net Cash Flow for Q1 2026 was -$1.2 million at Biomerica, down from -$509000.0 in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $6.4 million in Q2 2023 to a low of -$4.2 million in Q2 2022.
  • The 5-year median for Net Cash Flow is -$854000.0 (2023), against an average of -$356659.7.
  • The sharpest move saw Net Cash Flow soared 833.68% in 2022, then plummeted 1115.79% in 2023.
  • Year by year, Net Cash Flow stood at -$1.0 million in 2022, then rose by 14.6% to -$854000.0 in 2023, then rose by 7.38% to -$791000.0 in 2024, then soared by 35.65% to -$509000.0 in 2025, then crashed by 133.6% to -$1.2 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at -$1.2 million, -$509000.0, and $652000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.